|Bid||5.67 x 800|
|Ask||5.72 x 800|
|Day's Range||5.69 - 5.91|
|52 Week Range||2.25 - 7.73|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 12, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||16.11|
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth quarter. One of these stocks was Axcella Health Inc. (NASDAQ:AXLA). Is Axcella Health Inc. (NASDAQ:AXLA) a […]
Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced that management will be participating in the Piper Sandler 32nd Annual Virtual Healthcare Conference. The company will be webcasting its fireside chat at this event on November 24, 2020 at 9:00 a.m. ET.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...